News Agency
The Times

Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development

  • Written by PR Newswire
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
  • S-HiConTM is designed to maximize drug delivery and stability through high-concentration formulation
  • The platform can address challenges associated with viscosity and achieve stable liquid formulation for over 200 mg/mL subcutaneous administration

INCHEON, South Korea, Oct. 14, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global...

Read more: Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug...

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion